Attached files

file filename
S-1/A - S-1/A - Origo Acquisition Corps100441_s1.htm
EX-4.2 - EX-4.2 - Origo Acquisition Corps100441_ex4-2.htm
EX-4.1 - EX-4.1 - Origo Acquisition Corps100441_ex4-1.htm
EX-4.4 - EX-4.4 - Origo Acquisition Corps100441_ex4-4.htm
EX-4.3 - EX-4.3 - Origo Acquisition Corps100441_ex4-3.htm
EX-14 - EX-14 - Origo Acquisition Corps100441_ex14.htm
EX-4.6 - EXHIBIT 4.6 - Origo Acquisition Corps100441_ex4-6.htm
EX-4.5 - EXHIBIT 4.5 - Origo Acquisition Corps100441_ex4-5.htm
EX-10.4 - EXHIBIT 10.4 - Origo Acquisition Corps100441_ex10-4.htm
EX-99.1 - EX-99.1 - Origo Acquisition Corps100441_ex99-1.htm
EX-99.2 - EX-99.2 - Origo Acquisition Corps100441_ex99-2.htm
EX-10 - EXHIBIT 10.2 - Origo Acquisition Corps100441_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - Origo Acquisition Corps100441_ex10-1.htm
EX-10.3 - EX-10.3 - Origo Acquisition Corps100441_ex10-3.htm
EX-99.3 - EX-99.3 - Origo Acquisition Corps100441_ex99-3.htm
EX-10.6 - EXHIBIT 10.6 - Origo Acquisition Corps100441_ex10-6.htm
EX-10.8 - EXHIBIT 10.8 - Origo Acquisition Corps100441_ex10-8.htm
EX-10.7 - EXHIBIT 10.7 - Origo Acquisition Corps100441_ex10-7.htm

 

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the inclusion in this Amendment No. 1 to the Registration Statement of CB Pharma Acquisition Corp. on Form S-1, File No. 333-199558, of our report dated September 19, 2014, except for Notes 1 and 6 as to which the date is November 12, 2014, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the financial statements of CB Pharma Acquisition Corp. as of September 9, 2014 and for the period from August 26, 2014 (inception) through September 9, 2014, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.

 

/s/ Marcum llp

 

Marcum llp

New York, NY

November 12, 2014